AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...

FluMist is the only nasal vaccine approved in the U.S. It’s administered as two spritzes—one in each nostril—and stimulates ...

Michigan offers FluMist nasal vaccine delivery, aiming to increase flu vaccinations with the convenience of home administration for individuals aged 2 to 49.

FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...

AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...